Rafferty Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-59,464
| Closed | -$6.38M | – | 1166 |
|
|
2023
Q1 | $6.38M | Sell |
59,464
-13,725
| -19% | -$1.47M | 0.04% | 325 |
|
|
2022
Q4 | $8.05M | Sell |
73,189
-21,843
| -23% | -$2.4M | 0.07% | 260 |
|
|
2022
Q3 | $5.61M | Buy |
+95,032
| New | +$5.61M | 0.06% | 314 |
|
|
2022
Q2 | – | Sell |
-43,860
| Closed | -$1.66M | – | 1257 |
|
|
2022
Q1 | $1.66M | Buy |
+43,860
| New | +$1.66M | 0.01% | 667 |
|